Llanos, Anastacio C.

HRN: 22-55-99  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2023
02/09/2023
IV
500mg
Every 6H
Tetanus Infection
Waiting Final Action 
02/05/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/05/2023
02/11/2023
IVT
4.5 G
Q8
Tetanus Infection; T/c CAP-MR, UTI
Waiting Final Action 
02/12/2023
METRONIDAZOLE 500MG (TAB)
02/12/2023
02/19/2023
PER NGT
500mg
Q6
Tetanus Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: